Receptor for AGE (RAGE): signaling mechanisms in the pathogenesis of diabetes and its complications
- PMID: 22211895
- PMCID: PMC4501013
- DOI: 10.1111/j.1749-6632.2011.06320.x
Receptor for AGE (RAGE): signaling mechanisms in the pathogenesis of diabetes and its complications
Abstract
The receptor for advanced glycation endproducts (RAGE) was first described as a signal transduction receptor for advanced glycation endproducts (AGEs), the products of nonenzymatic glycation and oxidation of proteins and lipids that accumulate in diabetes and in inflammatory foci. The discovery that RAGE was a receptor for inflammatory S100/calgranulins and high mobility group box 1 (HMGB1) set the stage for linking RAGE to both the consequences and causes of types 1 and 2 diabetes. Recent discoveries regarding the structure of RAGE as well as novel intracellular binding partner interactions advance our understanding of the mechanisms by which RAGE evokes pathological consequences and underscore strategies by which antagonism of RAGE in the clinic may be realized. Finally, recent data tracking RAGE in the clinic suggest that levels of soluble RAGEs and polymorphisms in the gene encoding RAGE may hold promise for the identification of patients who are vulnerable to the complications of diabetes and/or are receptive to therapeutic interventions designed to prevent and reverse the damage inflicted by chronic hyperglycemia, irrespective of its etiology.
© 2011 New York Academy of Sciences.
Figures
Similar articles
-
The RAGE axis: a fundamental mechanism signaling danger to the vulnerable vasculature.Circ Res. 2010 Mar 19;106(5):842-53. doi: 10.1161/CIRCRESAHA.109.212217. Circ Res. 2010. PMID: 20299674 Free PMC article. Review.
-
Unlocking the biology of RAGE in diabetic microvascular complications.Trends Endocrinol Metab. 2014 Jan;25(1):15-22. doi: 10.1016/j.tem.2013.08.002. Epub 2013 Sep 3. Trends Endocrinol Metab. 2014. PMID: 24011512 Free PMC article. Review.
-
Receptor for AGE (RAGE) and its ligands-cast into leading roles in diabetes and the inflammatory response.J Mol Med (Berl). 2009 Mar;87(3):235-47. doi: 10.1007/s00109-009-0439-2. Epub 2009 Feb 3. J Mol Med (Berl). 2009. PMID: 19189073 Free PMC article. Review.
-
Signal transduction in receptor for advanced glycation end products (RAGE): solution structure of C-terminal rage (ctRAGE) and its binding to mDia1.J Biol Chem. 2012 Feb 10;287(7):5133-44. doi: 10.1074/jbc.M111.277731. Epub 2011 Dec 21. J Biol Chem. 2012. PMID: 22194616 Free PMC article.
-
Glycation, inflammation, and RAGE: a scaffold for the macrovascular complications of diabetes and beyond.Circ Res. 2003 Dec 12;93(12):1159-69. doi: 10.1161/01.RES.0000103862.26506.3D. Circ Res. 2003. PMID: 14670831 Review.
Cited by
-
Glycation and oxidative stress in the failure of dental implants: a case series.BMC Res Notes. 2013 Jul 26;6:296. doi: 10.1186/1756-0500-6-296. BMC Res Notes. 2013. PMID: 23890159 Free PMC article.
-
Insulin-mediated immune dysfunction in the development of preeclampsia.J Mol Med (Berl). 2021 Jul;99(7):889-897. doi: 10.1007/s00109-021-02068-0. Epub 2021 Mar 25. J Mol Med (Berl). 2021. PMID: 33768298 Review.
-
Receptor-mediated toxicity of human amylin fragment aggregated by short- and long-term incubations with copper ions.Mol Cell Biochem. 2017 Jan;425(1-2):85-93. doi: 10.1007/s11010-016-2864-1. Epub 2016 Nov 1. Mol Cell Biochem. 2017. PMID: 27804051
-
Integrated analysis of gene expression changes associated with coronary artery disease.Lipids Health Dis. 2019 Apr 9;18(1):92. doi: 10.1186/s12944-019-1032-5. Lipids Health Dis. 2019. PMID: 30961613 Free PMC article.
-
Icariside II ameliorates endothelial dysfunction by regulating the MAPK pathway via miR-126/SPRED1 in diabetic human cavernous endothelial cells.Drug Des Devel Ther. 2018 Jun 13;12:1743-1751. doi: 10.2147/DDDT.S166734. eCollection 2018. Drug Des Devel Ther. 2018. PMID: 29942117 Free PMC article.
References
-
- Forlenza GP, Paradise Black NM, McNamara EG, Sullivan SE. Ankyloglossia, exclusive breastfeeding, and failure to thrive. Pediatrics. 2010;125:e1500–e1504. - PubMed
-
- Peng H, Hagopian W. Environmental factors in the development of Type 1 diabetes. Rev. Endocr. Metab. Disord. 2006;7:149–162. - PubMed
-
- International Diabetes Federation IDF Diabetes Atlas. Epidemiology and Morbidity. International Diabetes Federation. Available from: http://www.idf.org.
-
- Sweat V, Bruzzese JM, Albert S, et al. The Banishing Obesity and Diabetes in Youth (BODY) Project: description and feasibility of a program to halt obesity-associated disease among urban high school students. J. Community Health. 2011 In press. - PubMed
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical